TheCardiovascular
Knowledge baseToolsDrugsCoursesTestsAtlas
⌘K
Log inBecome a member
Articles/🟠 Management of multivessel disease in patients with ACS undergoing PCI

Relaterade artiklar

  • Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Multivessel Coronary Artery Disease
  • 🟠 Antithrombotic regimens in patients with ACS with and without an indication for oral anticoagulation
  • Complete Versus Culprit-Only Revascularization in Acute Coronary Syndrome
  • 🟠 Reperfusion therapy (primary PCI, fibrinolysis) in patients with acute coronary syndromes (STEMI, NSTEMI, unstable angina)
  • 🟠 Prasugrel (Effient, Efient, Prasita)

Relaterade kalkylatorer

  • Mehran-Score för kontrastnefropati efter PCI
  • DAPT-Score (Dual Antiplatelet Therapy)
  • ARC-HBR-kriterier för hög blödningsrisk
  • TIMI Risk Index
  • Observatoire Regional Breton sur l'Infarctus (ORBI) riskscore

Relaterade tester

  • Management of Acute Coronary Syndromes — In patients presenting with NSTE-ACS and multivessel disease (MVD), what is the …
  • Management of Acute Coronary Syndromes — In patients undergoing a primary PCI strategy, what is the role of pretreatment …
  • Management of Acute Coronary Syndromes — In patients undergoing PCI, what is the recommended routine use of a UFH bolus d…
  • Management of Acute Coronary Syndromes — In patients with chronic kidney disease undergoing invasive strategies for acute…
  • Management of Acute Coronary Syndromes — In P2Y12 receptor inhibitor-nave patients undergoing PCI, which antiplatelet the…
Reference

🟠 Management of multivessel disease in patients with ACS undergoing PCI

Updated January 25, 2025

← All articles

Relaterade artiklar

  • Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Multivessel Coronary Artery Disease
  • 🟠 Antithrombotic regimens in patients with ACS with and without an indication for oral anticoagulation
  • Complete Versus Culprit-Only Revascularization in Acute Coronary Syndrome
  • 🟠 Reperfusion therapy (primary PCI, fibrinolysis) in patients with acute coronary syndromes (STEMI, NSTEMI, unstable angina)
  • 🟠 Prasugrel (Effient, Efient, Prasita)

Relaterade kalkylatorer

  • Mehran-Score för kontrastnefropati efter PCI
  • DAPT-Score (Dual Antiplatelet Therapy)
  • ARC-HBR-kriterier för hög blödningsrisk
  • TIMI Risk Index
  • Observatoire Regional Breton sur l'Infarctus (ORBI) riskscore

Relaterade tester

  • Management of Acute Coronary Syndromes — In patients presenting with NSTE-ACS and multivessel disease (MVD), what is the …
  • Management of Acute Coronary Syndromes — In patients undergoing a primary PCI strategy, what is the role of pretreatment …
  • Management of Acute Coronary Syndromes — In patients undergoing PCI, what is the recommended routine use of a UFH bolus d…
  • Management of Acute Coronary Syndromes — In patients with chronic kidney disease undergoing invasive strategies for acute…
  • Management of Acute Coronary Syndromes — In P2Y12 receptor inhibitor-nave patients undergoing PCI, which antiplatelet the…
The Cardiovascular

Clinical reviews, calculators and code systems for healthcare. Every recommendation carries its level of evidence and its source.

Become a member→
Knowledge
  • All areas
  • Articles
  • Symptoms
  • Drugs
  • Guidelines
  • Image library
  • Search
Tools
  • Calculators
  • Reference values
  • Diagnosis codes
  • Procedure Codes
  • Procedures
Learn
  • Courses
  • Knowledge tests
  • My account
About the site
  • Authors
  • Contact
  • Terms
  • Privacy policy
© 2026 Rawshani Research AB. All rights reserved.The content is intended for healthcare professionals and does not replace clinical judgement.
Saved

Become a member today

Become a member